# US 2013/0253295 A1 · System and method for determining an in vivo concentration of a small molecule substance of interest in a noninvasive manner

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253295 A1
- Document ID: US20130253295A1
- Status: Published application
- Kind: A1
- Application number: 13/758,867
- Filed: 2013-02-04
- Published: 2013-09-26
- Earliest claimed: 2012-02-03
- Assignees: University of Maryland, Baltimore County
- Inventors: Leah TOLOSA; Xudong GE; Yordan KOSTOV; Michael TOLOSA; Govind RAO
- Web page: https://patentgrep.com/patent/US20130253295A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 10/0045: {Devices for taking samples of body liquids}
- B01L 3/5029: {using swabs}
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- A61B 5/15: Devices for taking samples of blood
- A61B 5/150343: {Collection vessels for collecting blood samples from the skin surface, e.g. test tubes, cuvettes (sampling from within body cavities A61B5/150015, A61B5/150045)}
- B01L 2300/0663: Whole sensors
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Systems and methods for determining an in vivo concentration of a small molecule substance of interest is provided that takes advantage of the semi-permeable nature of skin, which allows small molecules to passively diffuse through the skin and onto the skin surface. The systems and methods of the present invention allow for the collection of these small molecules that have passively diffused through the skin without skin disruption or breaking of the skin. The systems and methods of the present invention are noninvasive, painless and safe even for delicate newborns, and are particularly suited for the determination of blood glucose in newborns and infants in a noninvasive manner.

## Claims

### Claim 1

A method of determining an in vivo concentration of a small molecule substance of interest in a subject, wherein the small molecule substance of interest has a molecular size that is capable of passively diffusing through the skin of the subject, the method comprising:
placing a collector for the small molecule substance of interest in contact with an area of the skin of the subject;
maintaining the collector in contact with the skin area for a predetermined time that is sufficient to collect at least some of the small molecule substance of interest that has passively diffused through the skin;
measuring a concentration of the small molecule substance of interest collected by the collector; and
extrapolating an in vivo concentration of the small molecule substance of interest based on the measured concentration of the small molecule substance of interest that passively diffused through the skin and that was collected by the collector.

### Claim 2 (depends on 1)

The method of claim 1, wherein the small molecule substance of interest comprises glucose, lactate, amino acid, sodium or calcium.

### Claim 3 (depends on 1)

The method of claim 1, wherein the collector comprises a swab moistened with buffer solution, and the swab is pressed against the skin for the predetermined time.

### Claim 4 (depends on 1)

The method of claim 1, further comprising washing the skin area for a predetermined period of time prior to placing the collector in contact with the skin area.

### Claim 5 (depends on 4)

The method of claim 4, wherein the collector comprises a solution that is dispensed onto the skin with a syringe, maintained on the skin for the predetermined time and removed from the skin with the syringe.

### Claim 6

A method of determining blood glucose in a subject, comprising:
placing a glucose collector in contact with an area of the skin of the subject, wherein the glucose collector is adapted to collect glucose that has passively diffused through the skin of the subject (“skin glucose”);
maintaining the glucose collector in contact with the skin area for a predetermined time that is sufficient to collect at least some of the skin glucose;
measuring a concentration of the skin glucose collected by the glucose collector; and
extrapolating blood glucose concentration in the subject based on the measured skin glucose concentration.

### Claim 7 (depends on 6)

The method of claim 6, wherein the glucose collector comprises a swab moistened with buffer solution, and the swab is pressed against the skin for the predetermined time.

### Claim 8 (depends on 6)

The method of claim 6, further comprising washing the skin area for a predetermined period of time prior to placing the collector in contact with the skin area.

### Claim 9 (depends on 8)

The method of claim 8, wherein the collector comprises a solution that is dispensed onto the skin with a syringe, maintained on the skin for the predetermined time and removed from the skin with the syringe.

### Claim 10 (depends on 6)

The method of claim 6, wherein the skin glucose concentration is measured using a glucose binding protein sensor.

### Claim 11 (depends on 10)

The method of claim 10, wherein the glucose binding protein sensor comprises a signal transducing fluorophore and a reference fluorophore.

### Claim 12 (depends on 11)

The method of claim 11, wherein the glucose binding protein sensor is immobilized on Sepharose beads.

### Claim 13 (depends on 11)

The method of claim 11, wherein the signal transducing fluorophore comprises acrylodan and the reference fluorophore comprises a ruthenium metal ligand complex or a europium metal ligand complex.

### Claim 14 (depends on 11)

The method of claim 11, wherein the glucose collector comprises a swab moistened with buffer solution, and wherein a concentration of skin glucose on the swab is measured by:
submerging the swab containing skin glucose in a buffer solution for a predetermined time that is sufficient to transfer at least some of the skin glucose from the swab to the buffer solution;
placing at least some of the skin glucose containing buffer solution in contact with the glucose binding protein sensor;
measuring the fluorescence response of the glucose binding protein sensor after it has come into contact with the skin glucose containing buffer solution; and
calculating a skin glucose concentration value based on the fluorescence response of the glucose binding protein sensor.

### Claim 15 (depends on 14)

The method of claim 14, wherein the fluorescence response of the glucose binding protein sensor is determined with a fluorimeter.

### Claim 16 (depends on 15)

The method of claim 15, wherein the fluorimeter is adapted to perform lifetime assisted ratiometric sensing.

### Claim 17 (depends on 7)

The method of claim 7, wherein the swab comprises:
a housing;
a recess formed in the housing; and
a glucose absorbing material positioned in the recess such that when the swab is pressed against the skin the glucose absorbing material comes in contact with the skin.

### Claim 18 (depends on 17)

The method of claim 17, wherein the housing comprises a pliable plastic housing.

### Claim 19 (depends on 14)

The method of claim 14, wherein the swab containing skin glucose is submerged in buffer solution by placing the swab in a vessel that contains the buffer solution.

### Claim 20 (depends on 19)

The method of claim 19, wherein the vessel comprises:
a reservoir for holding the buffer solution; and
a flexible septum attached to the reservoir and adapted to receive a syringe for withdrawing a sample of the buffer solution.
